Cover Image

Can antibody conjugated nanomicelles alter the prospect of antibody targeted therapy against schistosomiasis mansoni?

Show other versions (1)

Saved in:

Bibliographic Details
Main Authors:	Eglal I. Amer (Author), Sonia R. Allam (Author), Aceel Y. Hassan (Author), Esmail M. El-Fakharany (Author), Mona M. Agwa (Author), Sherine N. Khattab (Author), Eman Sheta (Author), Marwa H. El-Faham (Author)
Format:	Book
Published:	Public Library of Science (PLoS), 2023-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Can antibody conjugated nanomicelles alter the prospect of antibody targeted therapy against schistosomiasis mansoni?
by: Eglal I Amer, et al.
Published: (2023)

Treatment of Schistosoma mansoni with miltefosine in vitro enhances serological recognition of defined worm surface antigens.
by: Marwa H El-Faham, et al.
Published: (2017)

Antibody drug conjugates in the clinic
by: Edidiong Udofa, et al.
Published: (2024)

Antibody-drug conjugates for cancer therapy
by: Anna Grzywa
Published: (2021)

Antibody-Drug Conjugates: The Last Decade
by: Nicolas Joubert, et al.
Published: (2020)

Antibody-Drug Conjugate to Treat Meningiomas
by: Kai Chen, et al.
Published: (2021)

Interrogating heterogeneity of cysteine-engineered antibody-drug conjugates and antibody-oligonucleotide conjugates by capillary zone electrophoresis-mass spectrometry
by: Tian Xu, et al.
Published: (2023)

Antibody-drug conjugates: Recent advances in payloads
by: Zhijia Wang, et al.
Published: (2023)

Exploration of the antibody-drug conjugate clinical landscape
by: Heather Maecker, et al.
Published: (2023)

Therapeutic index improvement of antibody-drug conjugates
by: Hans-Peter Gerber, et al.
Published: (2023)

Antibody-drug conjugates combinations in cancer treatment
by: Giulia Pretelli, et al.
Published: (2024)

In Vivo Evaluation of an Antibody-Functionalized Lipoidal Nanosystem for Schistosomiasis Intervention
by: Tayo A. Adekiya, et al.
Published: (2022)

Ectopic Cutaneous Schistosomiasis mansoni in the Sacral Region
by: Pedro Raso, et al.
Published: (2010)

Incorporation of Unnatural Amino Acid into Antibody Fragment for Creating a Stable Antibody Drug Conjugate
by: Andri Wardiana, et al.
Published: (2021)

Toward Homogenous Antibody Drug Conjugates Using Enzyme-Based Conjugation Approaches
by: Ahmad Fawzi Hussain, et al.
Published: (2021)

Targeting cancer with antibody-drug conjugates: Promises and challenges
by: Alexis Q. Dean, et al.
Published: (2021)

Antibody-drug conjugates: Recent advances in linker chemistry
by: Zheng Su, et al.
Published: (2021)

Recent advances of antibody drug conjugates for clinical applications
by: Pengxuan Zhao, et al.
Published: (2020)

The Potential of Topoisomerase Inhibitor-Based Antibody-Drug Conjugates
by: Seungmin Han, et al.
Published: (2022)

Linkers: An Assurance for Controlled Delivery of Antibody-Drug Conjugate
by: Rotimi Sheyi, et al.
Published: (2022)

Antimelanocyte antibodies: A possible role in patients with vitiligo
by: Maha A El-Gayyar, et al.
Published: (2020)

Osteopontin Is Upregulated in Human and Murine Acute Schistosomiasis Mansoni.
by: Thiago Almeida Pereira, et al.
Published: (2016)

Bispecific antibody drug conjugates: Making 1+1>2
by: Yilin Gu, et al.
Published: (2024)

Advancing antibody-drug conjugates in gynecological malignancies: myth or reality?
by: Marta Nerone, et al.
Published: (2022)

Antibody-Drug Conjugates for Cancer Therapy: Chemistry to Clinical Implications
by: Nirnoy Dan, et al.
Published: (2018)

An Overview of Antibody Conjugated Polymeric Nanoparticles for Breast Cancer Therapy
by: Alberto Juan, et al.
Published: (2020)

Advances in Targeted Therapy of Breast Cancer with Antibody-Drug Conjugate
by: Md Abdus Subhan, et al.
Published: (2023)

Site-Specific Antibody Conjugation to Engineered Double Cysteine Residues
by: Qun Zhou, et al.
Published: (2021)

Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidences
by: Marilia Barreca, et al.
Published: (2022)

Association between Schistosomiasis mansoni and hepatitis C: systematic review
by: Daniele Silva de Moraes Van-Lume, et al.
Published: (2013)

Schistosomiasis mansoni in families of fishing workers of endemic area of Alagoas
by: Andrea Gomes Santana de Melo, et al.
Published: (2018)

Ocular toxicity and mitigation strategies for antibody drug conjugates in gynecologic oncology
by: Debra L. Richardson
Published: (2023)

Emerging role of mucins in antibody drug conjugates for ovarian cancer therapy
by: Shabnam Malik, et al.
Published: (2024)

Intracellular trafficking of new anticancer therapeutics: antibody–drug conjugates
by: Kalim M, et al.
Published: (2017)

Development of and insights from systems pharmacology models of antibody‐drug conjugates
by: Inez Lam, et al.
Published: (2022)

Disitamab vedotin: a novel antibody-drug conjugates for cancer therapy
by: Fan Shi, et al.
Published: (2022)

Patient, industry, and regulatory perspective on antibody‐drug conjugates dose optimization
by: Salaheldin Hamed, et al.
Published: (2024)

Prediction of Human Pharmacokinetics of Antibody-Drug Conjugates From Nonclinical Data
by: Chunze Li, et al.
Published: (2019)

Antibody-Drug Conjugates in the Pipeline for Treatment of Melanoma: Target and Pharmacokinetic Considerations
by: Ina Lami, et al.
Published: (2024)

Antibody-Drug Conjugates: Ushering in a New Era of Cancer Therapy
by: Joshua Hurwitz, et al.
Published: (2023)